CD274 and neoplasm: When the tumor volume reached 80–100 mm3, the mice were randomly divided into four treatment groups (n = 4 each): PBS, PD-L1 inhibitor BMS-8, PD-L1 monoclonal antibody, and PCC16 (Fig. 7A).